This is particularly relevant for: Short-acting agents (exenatide immediate-release, lixisenatide) May require timing separation from oral medications, particularly those requiring rapid absorption Weekly agents (semaglutide, dulaglutide, exenatide extended-release) Generally have minimal impact on oral contraceptive effectiveness Warfarin/coumarin anticoagulants More frequent INR monitoring may be advised when starting GLP-1 therapy Oral semaglutide (Rybelsus) has specific administration requirements (taking on an empty stomach with a small amount of water) to ensure proper absorption
Zepbound is not appropriate for those with insulin-dependent diabetes
Semaglutide works by mimicking the action of glucagon-like peptide 1 (GLP-1) a naturally occurring hormone that has the following effects: Stimulates insulin production to help regulate blood sugar Inhibits glucagon release, slowing the release of sugar into the blood causing the body to burn more fat Slows gastric emptying to make you feel full longer Reduces appetite (because you feel full) Together, these effects can help slow the conversion of sugar to fat, burn more fat, make you feel less hungry, and adhere to a healthy diet, all of which make it easier to manage weight and blood sugar
Davies MJ, Bain SC, Atkin SL, et al
We identified multi-faceted effects of GPX4 inhibitor, RSL3, in suppressing thyroid cancer cell survival
Impact of host factors and invasive meningococci on bacterial adhesion, proliferation, primary nasal epithelial barrier function, and immune response